NRx Pharmaceuticals has successfully completed the manufacturing process validation for preservative-free ketamine and confirmed two-year stability data showing the drug remains potent and sterile without preservatives. This milestone prepares NRx to supply the drug immediately upon FDA approval expected by November 10, 2026. The drug addresses shortages and has potential for treating suicidal ideation in depression. NRx aims for a labeled shelf life of three years or more, enhancing availability for hospitals and clinics.
NRx Pharmaceuticals' recent manufacturing milestone for preservative-free ketamine provides context for readers. For those tracking the health sector, as of Oct 19, 2026 18:43 WIB, 68 of 150 US health stocks on Pluang rose while 54 fell. Among notable movers, IOVA gained 1.32% to USD 13.80 with a typical hold time of 2 days, SANA also rose 1.32% to USD 2.30 with a 24-day hold, whereas SNY declined 1.28% to USD 40.09 with a much longer hold time of 94 days.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
